Histopathology (1999) 35:55866
None of it is set in stone, because your body is not static either
In general, patients with the following characteristics may be good candidates for Tirzepatide: A Body Mass Index (BMI) of 30 or higher A Body Mass Index (BMI) of 27 or higher when at least one comorbidity is present, such as insulin resistance, hypertension, high cholesterol, sleep apnea, or gout
When choosing a peptide, consider the target: central gonadotropin drive (gonadorelin, kisspeptin) versus growth-hormone mediated improvements (tesamorelin, CJC-1295)
Furthermore, the integration of temporal and spatial omics profiling may enable dynamic monitoring of signaling rewiring, informing the design of context specific, resistance-preemptive regimens